Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
- PMID: 38606570
- PMCID: PMC11010589
- DOI: 10.2807/1560-7917.ES.2024.29.15.2400178
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Abstract
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7-98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.
Keywords: EuroMOMO; Excess mortality; respiratory infections; surveillance.
Conflict of interest statement
Figures
References
-
- Vestergaard LS, Nielsen J, Richter L, Schmid D, Bustos N, Braeye T, et al. Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020. Euro Surveill. 2020;25(26):2001214. 10.2807/1560-7917.ES.2020.25.26.2001214 - DOI - PMC - PubMed
-
- Nørgaard SK, Vestergaard LS, Nielsen J, Richter L, Schmid D, Bustos N, et al. Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020. Euro Surveill. 2021;26(2):2002023. 10.2807/1560-7917.ES.2021.26.1.2002023 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical